16.32
-0.17 (-1.03%)
-0.17 (-1.03%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Celldex Therapeutics Inc | CLDX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.17 | -1.03% | 16.32 | 00:00:01 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 16.32 | 16.18 | 17.05 | 16.53 | 16.49 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 15.00 | 100.00 | 85.00 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,889 | 243,866 | $ 16.43 | $ 4,007,701 | 859,528 | 1.50 - 19.32 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:55:50 | 4 | $ 16.01 | USD |
Celldex Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 638.54M | 39.13M | 39.11M | $ 3.57M | $ - | -3.58 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 16.80% |
Celldex Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLDX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 15.79 | 17.2375 | 15.28 | 16.26 | 441,772 | 0.53 | 3.36% |
| 1 Month | 12.00 | 19.32 | 11.88 | 15.91 | 965,023 | 4.32 | 36.0% |
| 3 Months | 10.41 | 19.32 | 9.66 | 13.55 | 707,659 | 5.91 | 56.77% |
| 6 Months | 2.65 | 19.32 | 2.0511 | 9.20 | 1,885,536 | 13.67 | 515.85% |
| 1 Year | 2.32 | 19.32 | 1.50 | 8.40 | 1,082,999 | 14.00 | 603.45% |
| 3 Years | 2.94 | 19.32 | 0.17 | 3.06 | 1,401,405 | 13.38 | 455.1% |
| 5 Years | 12.95 | 19.32 | 0.17 | 4.11 | 1,706,141 | 3.37 | 26.02% |
Celldex Therapeutics Description
| Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140, and CDX-3379. |
